Terbutaline Sulfate NDC 62135-525

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-525Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0525Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-525-90	62135052590	90 TABLET in 1 BOTTLE (62135-525-90)Marketed from Feb 28, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Terbutaline Sulfate
Generic name (nonproprietary): terbutaline sulfate
Active ingredients: Terbutaline sulfate — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077152
Marketing start: Mar 25, 2005
Listing expires: Dec 31, 2026
Identifiers: Product ID 62135-525_459ef32e-2348-14bd-e063-6394a90a6a90SPL ID 459ef32e-2348-14bd-e063-6394a90a6a90SPL set ID 859267c6-3d14-4123-9b9d-4fc248f09726RxCUI 857677, 857683UNII 576PU70Y8EUPC 0362135524906, 0362135525903

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135052590 followed by a unit qualifier and the quantity

Package 62135-0525-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 10, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077152

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077152
Product	Strength	Form · route	Labeler	Product NDC
Terbutaline Sulfate	Terbutaline sulfate 2.5 mg/1	TabletOral	Chartwell RX, LLC.	62135-524
Terbutaline Sulfate	Terbutaline sulfate 5 mg/1	TabletOral	Lannett Company, Inc.	0527-1311
Terbutaline Sulfate	Terbutaline sulfate 2.5 mg/1	TabletOral	Lannett Company, Inc.	0527-1318